[The differential use of fibrinolysis activators and inhibitors in treating acute abscesses and gangrene of the lungs].
The authors examined 25 patients with acute abscesses and gangrene of the lungs to study the condition of the phagocyte system and its effect on processes of fibrin formation and destruction in the focus of inflammation. They found marked increase of the number of polymorphonuclear leucocytes and decrease of alveolar macrophages in lavage fluid of the diseased lung. The fibrinolytic, procoagulant, and oxygen-dependent metabolic activity of phagocytes was increased. With the degree of these changes and the clinical and endoscopic signs of the activity of the inflammatory process taken into account, the choice of the fibrinolysis activators and inhibitors for endobronchial administration can be differentiated and the results of treatment improved.
Shoĭkhet
Ia N
IaN
Dukov
L G
LG
Zaremba
S V
SV
Kostiuchenko
G I
GI
Shuster
L V
LV
D000208:Acute Disease; D000328:Adult; D000933:Antifibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001992:Bronchoalveolar Lavage Fluid / Q000166:cytology; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D005734:Gangrene / Q000188:drug therapy; D006801:Humans; D008168:Lung / Q000473:pathology*; D008169:Lung Abscess / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010586:Phagocytes / Q000187:drug effects; D011300:Preoperative Care / Q000379:methods
D000933:Antifibrinolytic Agents; D005343:Fibrinolytic Agents
Differentsirovannoe primenenie aktivatorov i ingibitorov fibrinoliza v lechenii ostrykh abstsessov i gangreny legkikh.